FIZE Medical is thrilled to announce that it has successfully raised $30 million in its latest funding round, a significant investment that underscores the confidence investors have in our innovative solutions. Our company is dedicated to revolutionizing patient care with groundbreaking technology that enables medical professionals to monitor renal output in real-time—a critical vital sign that plays a key role in assessing a patient's hemodynamic status across various clinical environments, including operating rooms and critical care units. This fresh infusion of capital will be instrumental in scaling our operations, enhancing our product development, and expanding our market reach. With these resources, we aim to refine our solution further, ensuring that healthcare providers can detect and respond to potential complications swiftly, ultimately improving patient outcomes and reducing the risk of hospitalization-related complications. At FIZE Medical, we are committed to innovating healthcare practices that save lives, and this funding will allow us to continue advancing our mission. We believe that by equipping clinicians with the tools they need, we can fundamentally transform the standards of patient monitoring. As we embark on this exciting chapter, we want to thank our investors for their unwavering support and our team for their relentless dedication to pushing the boundaries of medical technology. Together, we are paving the way for a healthier tomorrow.










.png&w=3840&q=75)


